摘要
目的：观察通痹胶囊治疗类风湿关节炎的临床疗效。方法随机入选病例410例，试验组308例，口服通痹胶囊，1粒/次，2～3次/日；对照组102例，口服壮骨关节丸，6 g/次，2次/日，60 d为1个疗程。结果治疗后，试验组的疾病疗效与中医证候疗效总有效率分别为89.78%、90.51%，与对照组比较，有统计学差异（ P ＜0.05）。结论通痹胶囊临床用于治疗类风湿性关节炎（寒湿阻络、肝肾两虚型痹证）安全、有效。
Objective The effect of Tongbi Capsules on rheumatoid arthritis（ RA）was observed in this paper. Meth-ods 410 patients were randomly divided into treated group and control group. 308 patients in treated group took one Tongbi Capsules each time,two or three times per day. While 102 patients in control group were treated routinely with Zhuanggu Guanjie pills,6 g for one time,twice a day with a course of sixty days in two groups. Results After a course of treatment, the total clinical effective rate and the rate of improvement of traditional Chinese medical syndrome was 89. 78% and 90.51%,respectively. Statistically,the difference between two groups was significant（P 〈0.05）. Conclusion Tongbi Capsules was effective and safe in the treating for rheumatoid arthritis（ syndrome of cold-dampness blocking collaterals, syndrome of deficiency of liver and kidney）.
出处
《药学研究》
CAS
2014年第8期485-487,共3页
Journal of Pharmaceutical Research
关键词
通痹胶囊
类风湿性关节炎
寒湿阻络证
肝肾两虚证
Tongbi CaPsules
Rheumatoid arthritis
Syndrome of cold - damPness blocking collaterals
Syndrome of deficiency of liver and kidney
